Impact of coronary artery calcium progression and statin therapy on clinical outcome in subjects with and without diabetes mellitus

American Journal of Cardiology

Volumn 111, Issue 3, 2013, Pages 356-361

  Kiramijyan, Sarkis ^a   Ahmadi, Naser ^a   Isma'Eel, Hussain ^a   Flores, Ferdinand ^a   Shaw, Leslee J ^b   Raggi, Paolo ^b   Budoff, Matthew J ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIUM; CORONARY RISK; COURSE EVALUATION; DIABETES MELLITUS; DISEASE COURSE; DISEASE MARKER; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SCORING SYSTEM;

CALCINOSIS; CALCIUM; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84872358426     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.09.033     Document Type: Article

References (28)

1. K. Pyorala, and M. Laakso Macrovascular disease in diabetes J. Mann, A. Teuscher, Diabetes in an Epidemiological Perspective 1983 Churchill Livingstone Edinburgh, United Kingdom 183 247
2. M. Laakso Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention J Intern Med 249 2001 225 235
3. M. Laakso, and S. Lehto Epidemiology of macrovascular disease in diabetes Diabetes Rev 5 1997 294 315
4. D.B. Simons, R.S. Schwartz, W.D. Edwards, P.F. Sheedy, J.F. Breen, and J.A. Rumberger Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study J Am Coll Cardiol 20 1992 1118 1126
5. G. Sangiorgi, J.A. Rumberger, A. Severson, W.D. Edwards, J. Gregoire, L.A. Fitzpatrick, and R.S. Schwartz Arterial calcification and not luminal stenosis is highly correlated atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using non-decalcifying methodology. Electron beam computed tomography and coronary artery disease: scanning for coronary artery calcification J Am Coll Cardiol 31 1998 126 133
6. P. Greenland, J.S. Alpert, G.A. Beller, E.J. Benjamin, M.J. Budoff, Z.A. Fayad, E. Foster, A. Hlatky, J.M. Hodgson, F.G. Kushner, M.S. Lauer, L.J. Shaw, S.C. Smith Jr., A.J. Taylor, S. Weintraub, and N.K. Wenger 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 56 2010 50 103
7. A.S. Agatston, W.R. Janowitz, F.J. Hildner, N.R. Zusmer, M. Viamonte Jr., and R. Detrano Quantification of coronary artery calcium using ultrafast computed tomography J Am Coll Cardiol 15 1990 827 832
8. T.Q. Callister, B. Cooil, S. Raya, N.J. Lippolis, D.J. Russo, and P. Raggi Coronary artery disease: improved reproducibility of calcium scoring with an electron beam-CT volumetric method Radiology 208 1998 807 814
9. R.S. Elkeles, I.F. Godland, M.D. Feher, M.B. Rubens, M. Roughton, F. Nugara, S.E. Humphries, W. Richmond, M.D. Flather PREDICT Study Group Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study Eur Heart J 29 2008 2244 2251
10. A. Becker, A.W. Leber, C. Becker, F. von Ziegler, J. Tittus, I. Schroeder, G. Steinbeck, and A. Knez Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: a prospective study in 716 patients over 8 years BMC Cardiovasc Disord 10 2008 27
11. D.V. Anand, E. Lim, D. Hopkins, R. Corder, L.J. Shaw, P. Sharp, D. Lipkin, and A. Lahiri Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy Eur Heart J 27 2006 713 721
12. R. Detrano, A.D. Guerci, J.J. Carr, D.E. Bild, G. Burke, A.R. Folsom, K. Liu, S. Shea, M. Szklo, D.A. Bluemke, D.H. O'Leary, R. Tracy, K. Watson, N.D. Wong, and R.A. Kronmal Coronary calcium as a predictor of coronary events in four racial or ethnic groups N Engl J Med 358 2008 1336 1345
13. P. Raggi, L.J. Shaw, D.S. Berman, and T.Q. Callister Prognostic value of coronary artery calcium screening in subjects with and without diabetes J Am Coll Cardiol 43 2004 1663 1669
14. S. Malik, M.J. Budoff, R. Katz, R.S. Blumenthal, A.G. Bertoni, K. Nasir, M. Szklo, R.G. Barr, and N.D. Wong Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the Multi-Ethnic Study of Atherosclerosis Diabetes Care 34 2011 2285 2290
15. R.S. Elkeles, I.F. Godsland, M.B. Rubens, M.D. Feher, F. Nugara, and M.D. Flather The progress of coronary heart disease in type 2 diabetes as measured by coronary calcium score from electron beam computed tomography (EBCT): the PREDICT study Atherosclerosis 197 2008 777 783
16. P. Raggi, B. Cooil, C. Ratti, T.Q. Callister, and M. Budoff Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus Hypertension 46 2005 238 243
17. P. Raggi, T.Q. Callister, and L.J. Shaw Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol lowering therapy Arterioslcer Thromb Vasc Biol 24 2004 1272 1283
18. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
19. J. Shepherd, S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimer, P.W. MacFarlane, J.H. McKillop, C.J. Packard West of Scotland Coronary Prevention Study Group Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
20. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
21. J.R. Downs, M. Clearfield, S. Weis, E. Whitney, D.R. Shapiro, P.A. Beere, A. Langendorfer, E.A. Stein, W. Kruyer, and A.M. Gotto Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS JAMA 279 1998 1615 1622
22. P.S. Sever, B. Dahlof, N.R. Poulter, H. Wedel, G. Beevers, M. Caulfield, R. Collins, S.E. Kjeldsen, A. Kristinsson, G.T. McInnes, J. Mehlsen, M. Nieminen, E. O'Brien, J. Ostergren ASCOT Investigators Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial Lancet 361 2003 1149 1158
23. The Long-Term Intervention With Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1998 1349 1357
24. M.J. Budoff, D. Yu, K. Nasir, R. Mehrotra, L. Chen, J. Takasu, N. Agrawal, S.T. Liu, and R.S. Blumenthal Diabetes and progression of coronary calcium under the influence of statin therapy Am Heart J 149 2005 695 700
25. J.G. Terry, J.J. Carr, E.O. Kouba, D.H. Davis, L. Menon, K. Bender, E.T. Chandler, T. Morgan, and J.R. Crouse Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the Coronary Artery Calcification Treatment With Zocor [CATZ] study) Am J Cardiol 99 2007 1714 1717
26. A. Schmermund, D. Baumgart, S. Mohlenkamp, P. Kriener, H. Pump, D. Grönemeyer, R. Seibel, and R. Erbel Natural history and topographic pattern of progression of coronary calcification in symptomatic patients. An electron-beam CT study Arterioscler Thromb Vasc Biol 21 2001 421 426
27. N. Ahmadi, S. Tsimikas, F. Hajsadeghi, A. Saeed, V. Nabavi, M.A. Bevinal, J. Kadakia, F. Flores, R. Ebrahimi, and M.J. Budoff Relation of oxidative biomarkers, vascular dysfunction, and progression of coronary artery calcium Am J Cardiol 105 2010 459 466
28. M.J. Budoff, J.E. Hokanson, K. Nasir, L.J. Shaw, G.L. Kinney, D. Chow, D. Demoss, V. Nuguri, V. Nabavi, R. Ratakonda, D.S. Berman, and P. Raggi Progression of coronary artery calcium predicts all-cause mortality JACC Cardiovasc Imaging 3 2010 1229 1236